Empagliflozin as an Adjunct to Insulin Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Empagliflozin Added on to Basal Insulin in Type 2 Diabetes Inadequately Controlled on Basal Insulin: A 78-Week Randomized, Double-Blind, Placebo-Controlled Trial
Diabetes Obes Metab 2015 Oct 01;17(10)936-948, J Rosenstock, A Jelaska, C Zeller, G Kim, UC Broedl, HJ WoerleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.